{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:06:08Z","timestamp":1783098368246,"version":"3.54.6"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T00:00:00Z","timestamp":1311033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00296-011-2039-z","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T19:44:38Z","timestamp":1311018278000},"page":"1819-1825","source":"Crossref","is-referenced-by-count":8,"title":["Weak CD4+\u00a0T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles"],"prefix":"10.1007","volume":"32","author":[{"given":"Diego","family":"Catal\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Aravena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Z\u00fa\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Sabugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Wurmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Larrondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cuchacovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Aguill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,19]]},"reference":[{"key":"2039_CR1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","volume":"26","author":"L Klareskog","year":"2008","unstructured":"Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L (2008) Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 26:651\u2013675","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"2039_CR2","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","volume":"56","author":"H Bang","year":"2007","unstructured":"Bang H, Egerer K, Gauliard A, Luthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56(8):2503\u20132511","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2039_CR3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.21739","volume":"54","author":"AH Helm-van Mil van der","year":"2006","unstructured":"van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54(4):1117\u20131121","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2039_CR4","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1002\/art.23127","volume":"56","author":"KN Verpoort","year":"2007","unstructured":"Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF, Drijfhout JW, de Vries RR, Breedveld FC, Huizinga TW, Pruijn GJ, Toes RE (2007) Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum 56(12):3949\u20133952","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2039_CR5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","volume":"171","author":"JA Hill","year":"2003","unstructured":"Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E (2003) Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171(2):538\u2013541","journal-title":"J Immunol"},{"issue":"1","key":"2039_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/art.25059","volume":"62","author":"AL Feitsma","year":"2010","unstructured":"Feitsma AL, van der Voort EI, Franken KL, El Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A (2010) Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Arthritis Rheum 62(1):117\u2013125","journal-title":"Arthritis Rheum"},{"key":"2039_CR7","doi-asserted-by":"crossref","unstructured":"van der Woude D, Lie BA, Lundstrom E, Balsa A, Feitsma AL, Houwing-Duistermaat JJ, Verduijn W, Nordang GB, Alfredsson L, Klareskog L, Pascual-Salcedo D, Gonzalez-Gay MA, Lopez-Nevot MA, Valero F, Roep BO, Huizinga TW, Kvien TK, Martin J, Padyukov L, de Vries RR, Toes RE (2010) Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 62(5):1236\u20131245. doi: 10.1002\/art.27366","DOI":"10.1002\/art.27366"},{"issue":"2","key":"2039_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.27272","volume":"62","author":"SY Bang","year":"2010","unstructured":"Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC (2010) Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum 62(2):369\u2013377","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2039_CR9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.1780350306","volume":"35","author":"A Gonzalez","year":"1992","unstructured":"Gonzalez A, Nicovani S, Massardo L, Bull P, Rodriguez L, Jacobelli S (1992) Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum 35(3):282\u2013289","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2039_CR10","first-page":"1067","volume":"26","author":"M Cuchacovich","year":"2008","unstructured":"Cuchacovich M, Catalan D, Wainstein E, Gatica H, Soto L, Aravena O, Pesce B, Sabugo F, Aguillon JC (2008) Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis. Clin Exp Rheumatol 26(6):1067\u20131073","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2039_CR11","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Despres N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, Menard HA (2004) Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 6(2):R142\u2013R150","journal-title":"Arthritis Res Ther"},{"key":"2039_CR12","doi-asserted-by":"crossref","unstructured":"van Bilsen JH, van Dongen H, Lard LR, van der Voort EI, Elferink DG, Bakker AM, Miltenburg AM, Huizinga TW, de Vries RR, Toes RE (2004) Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis. Proc Natl Acad Sci USA 101(49):17180\u201317185","DOI":"10.1073\/pnas.0407704101"},{"issue":"2","key":"2039_CR13","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.169.2.1068","volume":"169","author":"R Fritsch","year":"2002","unstructured":"Fritsch R, Eselbock D, Skriner K, Jahn-Schmid B, Scheinecker C, Bohle B, Tohidast-Akrad M, Hayer S, Neumuller J, Pinol-Roma S, Smolen JS, Steiner G (2002) Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol 169(2):1068\u20131076","journal-title":"J Immunol"},{"issue":"11","key":"2039_CR14","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1002\/art.21391","volume":"52","author":"I Auger","year":"2005","unstructured":"Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J (2005) Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum 52(11):3424\u20133432","journal-title":"Arthritis Rheum"},{"key":"2039_CR15","doi-asserted-by":"crossref","unstructured":"von Delwig A, Locke J, Robinson JH, Ng WF (2010) Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 62(1):143\u2013149","DOI":"10.1002\/art.25064"},{"issue":"10","key":"2039_CR16","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/art.27594","volume":"62","author":"EA James","year":"2010","unstructured":"James EA, Moustakas AK, Bui J, Papadopoulos GK, Bondinas G, Buckner JH, Kwok WW (2010) HLA-DR1001 presents \u201caltered-self\u201d peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets. Arthritis Rheum 62(10):2909\u20132918. doi: 10.1002\/art.27594","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2039_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/03009749850154447","volume":"27","author":"S Wakitani","year":"1998","unstructured":"Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T (1998) The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Scand J Rheumatol 27(5):381\u2013382","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"2039_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/08916930290024179","volume":"35","author":"KF Kong","year":"2002","unstructured":"Kong KF, Yeap SS, Chow SK, Phipps ME (2002) HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 35(4):235\u2013239","journal-title":"Autoimmunity"},{"issue":"11","key":"2039_CR19","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/art.20608","volume":"50","author":"HS Lee","year":"2004","unstructured":"Lee HS, Lee KW, Song GG, Kim HA, Kim SY, Bae SC (2004) Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum 50(11):3468\u20133475","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2039_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/art.11366","volume":"50","author":"Y Kochi","year":"2004","unstructured":"Kochi Y, Yamada R, Kobayashi K, Takahashi A, Suzuki A, Sekine A, Mabuchi A, Akiyama F, Tsunoda T, Nakamura Y, Yamamoto K (2004) Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 50(1):63\u201371","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2039_CR21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3899\/jrheum.080855","volume":"36","author":"HS El-Gabalawy","year":"2009","unstructured":"El-Gabalawy HS, Robinson DB, Hart D, Elias B, Markland J, Peschken CA, Smolik I, Montes-Aldana G, Schroeder M, Fritzler MJ, Cheang M, Oen K (2009) Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives. J Rheumatol 36(6):1130\u20131135","journal-title":"J Rheumatol"},{"issue":"2","key":"2039_CR22","first-page":"219","volume":"25","author":"T Furuya","year":"2007","unstructured":"Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kobashigawa T, Tokunaga K, Tsuchiya N, Kamatani N, Kotake S (2007) Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Clin Exp Rheumatol 25(2):219\u2013224","journal-title":"Clin Exp Rheumatol"},{"key":"2039_CR23","doi-asserted-by":"crossref","unstructured":"Okada Y, Suzuki A, Yamada R, Kochi Y, Shimane K, Myouzen K, Kubo M, Nakamura Y, Yamamoto K (2010) HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 69(8):1369\u20131370","DOI":"10.1136\/ard.2009.118018"},{"issue":"10","key":"2039_CR24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0198-8859(98)00067-6","volume":"59","author":"D Ou","year":"1998","unstructured":"Ou D, Mitchell LA, Tingle AJ (1998) A new categorization of HLA DR alleles on a functional basis. Hum Immunol 59(10):665\u2013676","journal-title":"Hum Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2039-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2039-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T20:57:54Z","timestamp":1712609874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2039-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,19]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2039"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2039-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,19]]}}}